Impact of PACV Administration on Vaccine Hesitancy
NCT04450940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1705
Last updated 2020-06-30
Summary
Our objective is to assess the impact of administering the PACV to parents of newborns. We also sought to assess the prevalence of vaccine hesitancy among parents of newborns in Houston, TX and to characterize the demographics of vaccine-hesitant parents.
Conditions
- Evaluating Impact of PACV on Vaccine Hesitancy Among Parents of Newborns
Interventions
- BEHAVIORAL
-
PACV survey
- BEHAVIORAL
-
Placebo survey
Sponsors & Collaborators
-
Seattle Children's Hospital
collaborator OTHER -
Baylor College of Medicine
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
More Related Trials
-
Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization
NCT05032391 ·Status: COMPLETED ·Phase: PHASE3
-
Educational Intervention to Improve Vaccine Acceptance
NCT01385501 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months
NCT01000311 ·Status: COMPLETED ·Phase: PHASE3
-
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
NCT06603090 ·Status: COMPLETED ·Phase: NA
-
Tailoring of Vaccine-Focused Messages: Moral Foundations
NCT02851459 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12
NCT00944034 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines
NCT05836012 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
NCT00474526 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
NCT00381615 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
NCT00667602 ·Status: COMPLETED ·Phase: PHASE3
-
Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model
NCT04123119 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Have to be Vaccinated MenBVac®
NCT01054053 ·Status: COMPLETED
-
Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
NCT02140762 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
NCT03537508 ·Status: COMPLETED ·Phase: PHASE3
-
NeisVac-C Single Prime Study in Infants
NCT01218451 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers
NCT00422292 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of Rotavirus Vaccine
NCT01199874 ·Status: COMPLETED ·Phase: PHASE4
-
Baby Vaccine Study (Sched3)
NCT02482636 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age
NCT00643916 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)
NCT00310856 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.
NCT02534935 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)
NCT06646744 ·Status: COMPLETED
-
Safety Surveillance of MenACWY-CRM Vaccine in Children
NCT01452438 ·Status: COMPLETED
-
Can we Reduce the Number of Vaccine Injections for Children?
NCT01129518 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)
NCT00953056 ·Status: COMPLETED ·Phase: PHASE1